Magazine
Latest Issue

Vaccines are being approved. Now comes the hard part

The swift development of a safe vaccine represents a scientific triumph. Rolling it out at scale and inoculating a critical mass of the population will require no less ingenuity

By Emily Lawford  

Photo: Victoria Jones/PA Wire/PA Images

Soon after Chinese scientists shared their information about the coronavirus genome in January, the race to find a vaccine began. Pharmaceutical companies around the world began developing over 270 different Covid-19 vaccines between them, conducting multiple tests simultaneously to speed up the process and using funding from various governments. “There has been a very big effort,” says David King, Cambridge Emeritus professor of physical chemistry and former chief scientific adviser to the government. “And I imagine that we will soon have four or five of these vaccines, all fully approved by the drug regulatory systems.”

The Pfizer/BioNTech vaccine,…

Register today to continue reading

You’ve hit your limit of three articles in the last 30 days. To get seven more, simply enter your email address below.

You’ll also receive our free e-book Prospect’s Top Thinkers 2020 and our newsletter with the best new writing on politics, economics, literature and the arts.

Prospect may process your personal information for our legitimate business purposes, to provide you with newsletters, subscription offers and other relevant information.

Click here to learn more about these purposes and how we use your data. You will be able to opt-out of further contact on the next page and in all our communications.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

We want to hear what you think about this article. Submit a letter to letters@prospect-magazine.co.uk

More From Prospect